0001209191-23-057698.txt : 20231207
0001209191-23-057698.hdr.sgml : 20231207
20231207110444
ACCESSION NUMBER: 0001209191-23-057698
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231205
FILED AS OF DATE: 20231207
DATE AS OF CHANGE: 20231207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FMR LLC
CENTRAL INDEX KEY: 0000315066
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41608
FILM NUMBER: 231471410
BUSINESS ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6175706339
MAIL ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER NAME:
FORMER CONFORMED NAME: FMR CORP
DATE OF NAME CHANGE: 19920717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Structure Therapeutics Inc.
CENTRAL INDEX KEY: 0001888886
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981480821
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (628) 229-9277
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ShouTi Inc.
DATE OF NAME CHANGE: 20211019
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-05
0
0001888886
Structure Therapeutics Inc.
GPCR
0000315066
FMR LLC
245 SUMMER STREET
BOSTON
MA
02210
0
0
1
1
See Remark 1
0
Ordinary Shares
45120
I
F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Ordinary Shares
530814
I
F-Prime Capital Partners Life Sciences Fund VI LP
American Depositary Shares
Ordinary Shares
4769400
1589800
I
Shares held by persons and entities whose shares are subject to reporting by the undersigned
American Depositary Shares
Ordinary Shares
123
41
I
FIMM, LLC
American Depositary Shares
2023-12-05
4
S
0
1368
62.46
D
Ordinary Shares
4104
2733
I
F-Prime Capital Partners Life Sciences Advisors Fund VI LP
American Depositary Shares
2023-12-05
4
S
0
16086
62.46
D
Ordinary Shares
48258
32169
I
F-Prime Capital Partners Life Sciences Fund VI LP
Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.
The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $62.35 to $62.63. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110.
Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.
Remark 3: F-Prime Capital Partners Life Sciences Advisors Fund VI LP (FPCPLSA) is the general partner of F-Prime Capital Partners Life Sciences Fund VI LP. FPCPLSA is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. FIMM, LLC is an indirect, wholly-owned subsidiary of FMR LLC.
Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
2023-12-07